Local, national & international business news and events.
The U.S. 150-day delinquency rate reached its highest level since at least January 1999 Forbearance provisions have helped foreclosure rates maintain historic lows IRVINE, Calif.–(BUSINESS WIRE)–#Foreclosure–CoreLogic® (NYSE: CLGX), a leading global property information, analytics and data-enabled solutions provider, today released its monthly
LENVIMA Plus Everolimus Also Showed Statistically Significant Improvement in PFS and ORR Endpoints Versus Sunitinib Results of Investigational Phase 3 KEYNOTE-581/CLEAR Trial (Study 307) to be Presented at Upcoming Medical Meeting KENILWORTH, N.J., & WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK): KEYTRUDA®
Deucravacitinib, the first and only novel, oral, selective tyrosine kinase 2 (TYK2) inhibitor in clinical studies across multiple immune-mediated diseases, showed significantly greater ACR 20 responses compared to placebo at 16 weeks and met all key secondary endpoints Deucravacitinib was well-tolerated with
JetBlue Adds 25 Additional Flights from the New York Area to Florida, California, and Top VFR Markets in the Caribbean Over Peak Thanksgiving Travel Dates NEW YORK–(BUSINESS WIRE)–JetBlue (NASDAQ: JBLU) today announced it is expanding service from New York City over the
Approval based on Phase 3 CheckMate -9LA trial results showing superior overall survival in patients with metastatic non-small cell lung cancer, regardless of PD-L1 expression or tumor histologies European Commission decision marks the first time a dual immunotherapy with limited chemotherapy is
New commitment-free ‘try and buy’ model allows businesses to swiftly adopt or expand unattended automation and simplify the purchasing decision process HOBOKEN, N.J.–(BUSINESS WIRE)–Organizations globally have been impacted by dynamic changes in recent months and are in critical need of efficiencies in
PITTSBURGH–(BUSINESS WIRE)–PPG (NYSE: PPG) today announced the appointment of Marvin Mendoza as global head of diversity, equity and inclusion (DE&I), effective Nov. 9, 2020. In this newly-developed role, Mendoza will be responsible for designing, leading and executing PPG’s global DE&I vision and
Election night can be nerve-wrecking. — FOX News
SHANGHAI & PRINCETON, N.J.–(BUSINESS WIRE)–LianBio, a biotechnology company focused on bringing paradigm-shifting medicines to patients in China and major Asian markets, today announced that it has received clearance from the Center for Drug Evaluation (CDE) of the China National Medical Products Administration